Licensed Vocational Nurse in Bellefontaine, OH Accepting Medicare

1 Licensed Vocational Nurse nurses found. Showing 1 - 1

Sydnae Collyn Hurlbut, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2739 County Road 91, Bellefontaine, OH 43311 Phone: 937-592-2901

News Archive

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before HIV

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before the emergence of HIV, according to new findings from Fred Hutchinson Cancer Research Center.

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

NTD treatments are cost-effective, report shows

"Recently, Hudson Institute's Center for Science in Public Policy, in partnership with the Global Network for Neglected Tropical Diseases, published a new report to highlight the links between NTDs and socio-economic prosperity," according to the network's "End the Neglect" blog.

Impax commences IPX159 Phase IIb trial in Restless Legs Syndrome

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced that it has initiated a Phase IIb trial of its drug candidate IPX159 in patients with moderate to severe Restless Legs Syndrome.

ImmunoCellular receives FDA IND clearance for ICT-121 Phase I trial in glioblastoma multiforme

ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.

Read more Medical News

› Verified 1 days ago